Human Gene TherapyVol. 28, No. 4 EditorialAAV Is Now a Medicine: We Had Better Get This RightTerence R. Flotte and Guangping GaoTerence R. FlotteEditor-in-ChiefSearch for more papers by this author and Guangping GaoEditorSearch for more papers by this authorPublished Online:1 Apr 2017https://doi.org/10.1089/hum.2017.29041.trfAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"AAV Is Now a Medicine: We Had Better Get This Right." Human Gene Therapy, 28(4), p. 307FiguresReferencesRelatedDetailsCited byFood and Drug Administration Guidance on Design of Clinical Trials for Gene Therapy Products with Potential for Genome Integration or Genome Editing and Associated Long-Term Follow-Up of Research Subjects Daniel Eisenman and Scott Swindle23 November 2022 | Applied Biosafety, Vol. 27, No. 4AAV capsid design: A Goldilocks challengeTrends in Molecular Medicine, Vol. 28, No. 3A Changing World in Gene Therapy Research: Exciting Opportunities for Medical Advancement and Biosafety Challenges Daniel Eisenman, Shaun Debold, and James Riddle24 November 2021 | Applied Biosafety, Vol. 26, No. 4AAV Vectors: Are They Safe? Arun Srivastava15 July 2020 | Human Gene Therapy, Vol. 31, No. 13-14Considerations on Preclinical Neuromuscular Disease Gene Therapy Studies31 March 2019CRISPR/Cas9 Inhibits Multiple Steps of HIV-1 Infection Lijuan Yin, Siqi Hu, Shan Mei, Hong Sun, Fengwen Xu, Jian Li, Weijun Zhu, Xiaoman Liu, Fei Zhao, Di Zhang, Shan Cen, Chen Liang, and Fei Guo13 November 2018 | Human Gene Therapy, Vol. 29, No. 11 Volume 28Issue 4Apr 2017 InformationCopyright 2017, Mary Ann Liebert, Inc.To cite this article:Terence R. Flotte and Guangping Gao.AAV Is Now a Medicine: We Had Better Get This Right.Human Gene Therapy.Apr 2017.307-307.http://doi.org/10.1089/hum.2017.29041.trfPublished in Volume: 28 Issue 4: April 1, 2017PDF download